Atlantic Trust Group LLC Grows Stake in Allscripts Healthcare Solutions, Inc. (MDRX)

Atlantic Trust Group LLC raised its position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 0.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,900 shares of the software maker’s stock after purchasing an additional 110 shares during the quarter. Atlantic Trust Group LLC’s holdings in Allscripts Healthcare Solutions were worth $420,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. FNY Partners Fund LP raised its holdings in shares of Allscripts Healthcare Solutions by 900.0% in the 1st quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock worth $101,000 after purchasing an additional 7,200 shares during the period. Invictus RG purchased a new position in shares of Allscripts Healthcare Solutions in the 1st quarter worth about $105,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Allscripts Healthcare Solutions by 9.5% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock worth $120,000 after purchasing an additional 816 shares during the period. Flinton Capital Management LLC raised its holdings in shares of Allscripts Healthcare Solutions by 4.1% in the 1st quarter. Flinton Capital Management LLC now owns 9,940 shares of the software maker’s stock worth $126,000 after purchasing an additional 392 shares during the period. Finally, Bank of Montreal Can raised its holdings in shares of Allscripts Healthcare Solutions by 60.2% in the 1st quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock worth $126,000 after purchasing an additional 3,724 shares during the period.

MDRX has been the topic of a number of research reports. Leerink Swann downgraded Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $15.00 to $13.00 in a report on Monday, June 19th. Piper Jaffray Companies restated a “hold” rating and issued a $14.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, July 21st. BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Saturday, June 24th. Jefferies Group LLC set a $17.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a report on Friday, August 25th. Finally, Cowen and Company upgraded Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $13.00 to $16.00 in a report on Monday. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $14.81.

ILLEGAL ACTIVITY WARNING: “Atlantic Trust Group LLC Grows Stake in Allscripts Healthcare Solutions, Inc. (MDRX)” was first reported by Stock Observer and is owned by of Stock Observer. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.thestockobserver.com/2017/09/13/atlantic-trust-group-llc-grows-stake-in-allscripts-healthcare-solutions-inc-mdrx.html.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 13.72 on Wednesday. The firm’s 50-day moving average price is $12.79 and its 200-day moving average price is $12.33. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $13.97. The firm’s market cap is $2.48 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.04). Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. During the same period in the prior year, the firm posted $0.14 EPS. Allscripts Healthcare Solutions’s revenue for the quarter was up 10.2% on a year-over-year basis. Equities research analysts expect that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current fiscal year.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply